Navigation Links
Lung Rx and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction
Date:2/10/2010

ch is a powerful combination to bring potentially life-saving treatments to patients."

About IPF

Idiopathic Pulmonary Fibrosis is a progressive, usually fatal disease that afflicts in excess of 100,000 persons in the United States alone.  According to the Coalition of Pulmonary Fibrosis, approximately 48,000 new patients are diagnosed with this devastating disease annually with 40,000 deaths from the disease each year -- about the same number of deaths as from breast cancer.  Within five years of diagnosis, progression of IPF leads to death in approximately 70% of patients.  There are currently no FDA-approved options for patients suffering from this life-threatening condition.

About PGD

Primary Graft Dysfunction is a leading cause of morbidity and mortality in patients following lung transplant surgery.  This complication that may affect up to 10%-25% of lung transplant patients.  PGD is also a significant risk factor for development of bronchiolitis obliterans syndrome, a chronic, scarring process that affects the small airways of the lungs and is a leading cause of death in lung transplant patients.

About Lung Rx and United Therapeutics

Lung Rx LLC, a wholly-owned subsidiary of United Therapeutics Corporation, is a biotechnology company focused on unmet medical needs in pulmonary medicine and pulmonary delivery of innovative therapeutic products.  United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.  [uthr-g]

About ImmuneWorks

Founded in 2006, ImmuneWorks, Inc. is a biotechnology company committed to developing safe and effective immune tolerance treatments for patients wit
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kinexus Announces the Launch of a New Protein Kinase Microarray
2. Goodwin Biotechnology Inc. and Macrocyclics Announce Collaboration
3. Brazilian Sugarcane Industry Association Stresses Need for Brazils Government to Announce Ethanol Import Tariff Cut as Soon as Possible
4. Dates Announced for IntertechPira's 5th Annual Biopolymers Symposium
5. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
6. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010
7. Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results
8. Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries
9. Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
10. Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors
11. Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Trigemina, Inc., a biopharmaceutical company focused on the ... products, announced today that the company has appointed Shashidhar ... officer. Dr. Kori brings over 30 years of clinical ... focused in the neuroscience and headache space. ... clinical team given his vast experience managing clinical development ...
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, the White ... of entrepreneurs from across the United States to talk about their experiences with innovation ... be chosen to be among the attendees. , One of the day’s aims is ...
(Date:8/3/2015)... , August 3, 2015 At ... Portland Hospital waved the shortfall of Jude ... stand normally for the first time.      ... http://photos.prnewswire.com/prnh/20150803/254229 ) The Selective Dorsal ... allowing him to carry out his wish to kick ...
(Date:8/3/2015)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), the pioneer ... today announced that it will host its First Quarter ... August 13, 2015 at 4:30 p.m. Eastern Time. ... of fiscal 2016 first quarter results.  A recorded version ... after the call at the Investor Relations portion of ...
Breaking Biology Technology:Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2
... FRAZER, Pa., Dec. 6, 2010 Cephalon, Inc. (Nasdaq: ... company,s Chairman and Chief Executive Officer, will not be ... will remain on a medical leave of absence indefinitely.  ... Operating Officer, will continue to perform Dr. Baldino,s day-to-day responsibilities ...
... Dec. 6, 2010 Investigators report no evidence of toxicity ... a gene therapy trial using a vector under development ... College London) to correct the inherited bleeding disorder. ... with low and intermediate doses of the vector expected to ...
... SIGNAL HILL, Calif., Dec. 6, 2010 The medical ... recognized by the U.S. Department of Health and Human ... therapeutic discovery."  The designation earns the company a grant ... Project designation and grant is provided for under the ...
Cached Biology Technology:Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely 2Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 2Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 3Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B 4Integrated Medical Systems' Technology Recognized as Qualified Therapeutic Discovery 2
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/27/2015)... ANGELES , July 27, 2015   ... evidence- and experience-based clinical improvement solutions, today announced ... solution is now available on Android smartphones and ... inpatient and post-care organizations can use ZynxCarebook to ... same patient,s condition, streamline care transitions to other ...
(Date:7/23/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) has ... of the Biometrics Industry 2015 " report ... biometrics market is likely to witness significant growth ... the uptake of multiple technologies available. The year ... growth of biometrics in existing applications as well ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... GSA BULLETIN science published online 9-20 March includes ... the Southern Pyrenees, and the western Gulf of Mexico. ... in south-central Chile, characterizing the source and age of ... pieces of mid-oceanic ridge found above ground, and large ...
... associated with storing nuclear waste and the possibility of ... may no longer be obstacles on the road to ... the University of Notre Dame, led by Thomas E. ... concurrent professor of chemistry and biochemistry, showcases Notre Dame ...
... WASHINGTON The water flowing through Venice,s famous canals ... not only because of a rising sea level. Although previous ... that the historic city continues to slowly sink, and even ... be continuing to subside, at a rate of about 2 ...
Cached Biology News:How old are these rocks, how were they made, and how long ago did these geologic changes happen? 2How old are these rocks, how were they made, and how long ago did these geologic changes happen? 3How old are these rocks, how were they made, and how long ago did these geologic changes happen? 4How old are these rocks, how were they made, and how long ago did these geologic changes happen? 5How old are these rocks, how were they made, and how long ago did these geologic changes happen? 6How old are these rocks, how were they made, and how long ago did these geologic changes happen? 7New paper by Notre Dame researchers describes method for cleaning up nuclear waste 2AGU: Venice hasn't stopped sinking after all 2AGU: Venice hasn't stopped sinking after all 3AGU: Venice hasn't stopped sinking after all 4
... polystyrene with frosted labeling surfaces, volume ... counting. 100% integrity tested. Linkage: This ... number, created to easily match Cornings ... yet, please order under the old ...
... CellBIND surface is produced by a ... more hydrophilic surface giving more consistent, ... and yields. CellBIND enhances cell attachment ... reduced serum or serum-free medium. • ...
iNOS/NOS Type II Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 150 µg Consult technical datasheet for details....
... 100-240 V, uses multiplex suspension array technology ... up to 100 proteins and peptides in ... is composed of up to 100 color-coded ... conjugated with a unique reactant specific to ...
Biology Products: